Jesper L. Kristensen

3.5k total citations
132 papers, 2.7k citations indexed

About

Jesper L. Kristensen is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jesper L. Kristensen has authored 132 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Organic Chemistry, 56 papers in Molecular Biology and 29 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jesper L. Kristensen's work include Chemical synthesis and alkaloids (27 papers), Psychedelics and Drug Studies (25 papers) and Neurotransmitter Receptor Influence on Behavior (23 papers). Jesper L. Kristensen is often cited by papers focused on Chemical synthesis and alkaloids (27 papers), Psychedelics and Drug Studies (25 papers) and Neurotransmitter Receptor Influence on Behavior (23 papers). Jesper L. Kristensen collaborates with scholars based in Denmark, United States and Sweden. Jesper L. Kristensen's co-authors include Mikael Begtrup, Per Vedsø, Gitte M. Knudsen, Matthias M. Herth, Gretchen M. Schroeder, Barry M. Trost, Anders A. Jensen, Szabolcs Lehel, Martin Hansen and Jesper T. Andreasen and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and ACS Nano.

In The Last Decade

Jesper L. Kristensen

130 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jesper L. Kristensen Denmark	28	1.4k	996	690	592	325	132	2.7k
Peter C. Meltzer United States	24	470 0.3×	547 0.5×	853 1.2×	139 0.2×	209 0.6×	61	1.8k
S. Wayne Mascarella United States	25	626 0.4×	1.8k 1.8×	1.4k 2.1×	125 0.2×	115 0.4×	98	2.7k
Amadeu Llebaria Spain	35	1.4k 1.0×	1.7k 1.7×	873 1.3×	168 0.3×	32 0.1×	153	3.5k
Matthias M. Herth Denmark	24	690 0.5×	859 0.9×	427 0.6×	98 0.2×	887 2.7×	128	2.1k
John W. Boja United States	28	443 0.3×	1.2k 1.2×	1.6k 2.3×	92 0.2×	160 0.5×	53	2.3k
Maƚgorzata Dukat United States	27	935 0.7×	1.3k 1.3×	794 1.2×	336 0.6×	14 0.0×	109	2.3k
Micah J. Niphakis United States	30	944 0.7×	1.3k 1.3×	490 0.7×	38 0.1×	112 0.3×	57	3.1k
Nicola Antonio Colabufo Italy	37	942 0.7×	2.3k 2.3×	837 1.2×	24 0.0×	172 0.5×	183	4.0k
Albert J. Robichaud United States	29	1.1k 0.8×	1.1k 1.1×	742 1.1×	67 0.1×	27 0.1×	74	2.8k
Francesco Berardi Italy	39	1.1k 0.8×	2.7k 2.8×	1.2k 1.8×	27 0.0×	131 0.4×	153	3.9k

Countries citing papers authored by Jesper L. Kristensen

Since Specialization

Citations

This map shows the geographic impact of Jesper L. Kristensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesper L. Kristensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesper L. Kristensen more than expected).

Fields of papers citing papers by Jesper L. Kristensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesper L. Kristensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesper L. Kristensen. The network helps show where Jesper L. Kristensen may publish in the future.

Co-authorship network of co-authors of Jesper L. Kristensen

This figure shows the co-authorship network connecting the top 25 collaborators of Jesper L. Kristensen. A scholar is included among the top collaborators of Jesper L. Kristensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesper L. Kristensen. Jesper L. Kristensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yang, Jesper L. Kristensen, & Kristi A. Kohlmeier. (2025). The Selective 5HT_2A Receptor Agonist, 25CN‐NBOH Exerts Excitatory and Inhibitory Cellular Actions on Mouse Medial Prefrontal Cortical Neurons. Synapse. 79(2). e70014–e70014. 1 indexed citations

Jensen, Anders A., et al.. (2024). Discovery and Structure–Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT_2A Receptor Agonists. Journal of Medicinal Chemistry. 67(9). 7224–7244. 4 indexed citations

Pottie, Eline, Christian B. M. Poulie, Ícaro A. Simon, et al.. (2023). Structure–Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT_2A Receptor Agonists. ACS Chemical Neuroscience. 14(15). 2727–2742. 12 indexed citations

Poulie, Christian B. M., Eline Pottie, Ícaro A. Simon, et al.. (2022). Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT_2AReceptor Agonists. Journal of Medicinal Chemistry. 65(18). 12031–12043. 16 indexed citations

Kędzierska, Ewa, Katarzyna M. Targowska‐Duda, Tomasz M. Wróbel, et al.. (2022). Funnel metadynamics and behavioral studies reveal complex effect of D2AAK1 ligand on anxiety-like processes. Scientific Reports. 12(1). 21192–21192. 1 indexed citations

Stéen, E. Johanna L., Jesper Tranekjær Jørgensen, Christoph Denk, et al.. (2021). Lipophilicity and Click Reactivity Determine the Performance of Bioorthogonal Tetrazine Tools in Pretargeted In Vivo Chemistry. ACS Pharmacology & Translational Science. 4(2). 824–833. 61 indexed citations

Battisti, Umberto Maria, Jesper Tranekjær Jørgensen, Vladimir Shalgunov, et al.. (2021). Direct Cu-mediated aromatic ¹⁸ F-labeling of highly reactive tetrazines for pretargeted bioorthogonal PET imaging. Chemical Science. 12(35). 11668–11675. 49 indexed citations

Johansen, Annette, Søren Holm, Sune H. Keller, et al.. (2019). Human biodistribution and radiation dosimetry of the 5-HT2A receptor agonist Cimbi-36 labeled with carbon-11 in two positions. EJNMMI Research. 9(1). 71–71. 8 indexed citations

Stéen, E. Johanna L., Jesper Tranekjær Jørgensen, Kerstin Johann, et al.. (2019). Trans-Cyclooctene-Functionalized PeptoBrushes with Improved Reaction Kinetics of the Tetrazine Ligation for Pretargeted Nuclear Imaging. ACS Nano. 14(1). 568–584. 62 indexed citations

10.

Hansen, Hanne D., et al.. (2017). Synthesis, radiofluorination, and preliminary evaluation of the potential 5‐HT_2A receptor agonists [¹⁸F]Cimbi‐92 and [¹⁸F]Cimbi‐150. Journal of Labelled Compounds and Radiopharmaceuticals. 60(12). 586–591. 2 indexed citations

11.

Kristensen, Jesper L. & Matthias M. Herth. (2017). Textbook of Drug Design and Discovery:In vivo imaging in drug discovery. Research at the University of Copenhagen (University of Copenhagen). 3 indexed citations

12.

Hansen, Hanne D., et al.. (2015). 11C-labeling and preliminary evaluation of pimavanserin as a 5-HT2A receptor PET-radioligand. Bioorganic & Medicinal Chemistry Letters. 25(5). 1053–1056. 13 indexed citations

13.

Leurs, Ulrike, Brian Lohse, Kasper D. Rand, et al.. (2014). Substrate- and Cofactor-independent Inhibition of Histone Demethylase KDM4C. ACS Chemical Biology. 9(9). 2131–2138. 24 indexed citations

14.

Nielsen, Birgitte, Lars Olsen, Ulf Madsen, et al.. (2014). Design, synthesis and in vitro pharmacology of GluK1 and GluK3 antagonists. Studies towards the design of subtype-selective antagonists through 2-carboxyethyl-phenylalanines with substituents interacting with non-conserved residues in the GluK binding sites. Bioorganic & Medicinal Chemistry. 22(19). 5368–5377. 6 indexed citations

15.

Ettrup, Anders, Søren Holm, Martin Hansen, et al.. (2013). Preclinical Safety Assessment of the 5-HT2A Receptor Agonist PET Radioligand [11C]Cimbi-36. Molecular Imaging and Biology. 15(4). 376–383. 42 indexed citations

16.

Ettrup, Anders, Nic Gillings, Agnete Dyssegaard, et al.. (2012). Development of an F-18-labelled 5-HT2A receptor agonist PET radioligand. Research at the University of Copenhagen (University of Copenhagen). 1 indexed citations

17.

Risgaard, Rune, Anders Ettrup, Thomas Balle, et al.. (2012). Radiolabelling and PET brain imaging of the α1-adrenoceptor antagonist Lu AE43936. Nuclear Medicine and Biology. 40(1). 135–140. 17 indexed citations

18.

Lohse, Brian, Jan B. L. Kristensen, Charlotte Helgstrand, et al.. (2011). Targeting Histone Lysine Demethylases by Truncating the Histone 3 Tail to Obtain Selective Substrate‐Based Inhibitors. Angewandte Chemie. 123(39). 9266–9269. 9 indexed citations

19.

Lohse, Brian, Jan B. L. Kristensen, Jan B. L. Kristensen, et al.. (2011). Targeting Histone Lysine Demethylases by Truncating the Histone 3 Tail to Obtain Selective Substrate‐Based Inhibitors. Angewandte Chemie International Edition. 50(39). 9100–9103. 30 indexed citations

20.

Hansen, Kasper B., Rasmus P. Clausen, Esben Jannik Bjerrum, et al.. (2005). Tweaking Agonist Efficacy at N-Methyl-d-aspartate Receptors by Site-Directed Mutagenesis. Molecular Pharmacology. 68(6). 1510–1523. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact